Page 30 - MI-2-1
P. 30

Microbes & Immunity                                                       Microbial involvement in ME/CFS



            manifestations of ME/CFS.  In addition, both genetic   (e.g., Coxiella burnetti) and mainly viral (e.g., Epstein-Barr,
                                  5,76
            and environmental factors can affect the gut microbiome,   Ross River, SARS-CoV-2), in triggering this disease. 82-84
            and shifts in local gut microbiota composition should   The recent pandemic of COVID-19 caused a serious
            be  evaluated in  ME/CFS.   Although  the  significance of   impairment in quality of life  and led to long COVID-19
                                 77
                                                                                      85
            the gut microbiome in health and disease is becoming   in numerous patients who “recovered” but did not return
            increasingly clear,  limitations must be addressed   to full health.  In this regard, long  COVID-19  shares
                           78
                                                                           86
            regarding studies of the gut microbiota and ME/CFS,   many phenotypic abnormalities with ME/CFS following
            such as differing results, small sample sizes, confounding   viral infections, including persistent chronic fatigue and
            variables, and lack of homogeneity of the microbial gene   myalgia.
            sequencing platforms. 45,55
              Butyrate and its precursor acetate are two of the most   6. Conclusion
            important SCFAs of microbial origin. Both metabolites   Research on patients with ME/CFS has revealed variable
            are reduced in ME/CFS patients likely due to the decrease   findings on alterations in gastrointestinal processes that
            of F. prausnitzii, Ruminococcus spp., Eubacterium rectale,   involve microbiota. Microbiome changes or metabolic
            and C. secundus in their gut microbiome (Table 1). Thus,   endotoxemia may be potential biomarkers of ME/CFS. The
            a deficiency of these intestinal homeostatic metabolites   progression of ME/CFS may begin with the loss of beneficial
            could contribute to a number of detrimental physiological   gut microorganisms, especially SCFA producers that are
            perturbations,  including  a  weakened  epithelial  barrier   reflected in plasma metabolite levels. These alterations may
            and increased intestinal inflammation, which results   result in metabolic and phenotypic shifts and in ME/CFS.
            in elevated plasma LPS levels in ME/CFS, indicative of   Randomized  controlled  trials  in  well-identified  patients
            microbial translocation.  In addition,  F.  prausnitzii and   with ME/CFS, using diet, FMT, and other approaches may
                               42
            Lachnospira (formerly Lactobacillus) rogosae are the major   benefit these patients and establish causality.
            bacterial species associated with the symptoms of ME/CFS
            and with individual and total Multidimensional Fatigue   Acknowledgments
            Inventory (MFI) scores. 45                         None.
              The cognitive problems detected in ME/CFS subjects
            could be related to alterations in the gut microbiota and also   Funding
            to a substantial decrease in Vitamin E levels. Tryptophan,   None.
            a precursor for serotonin, can be degraded by determined
            gut microorganisms, which may exert influence on brain   Conflict of interest
            function,  and on the pathophysiology of ME/CFS.  Thus,
                                                    80
                   79
            studying the changes in gut microbiome composition and   The authors declare that they do not have competing
            function may clarify how tryptophan metabolism affects   interests.
            serotonin concentrations, which may contribute to various   Author contributions
            symptoms of ME/CFS, such as depression and restless sleep.
                                                               Conceptualization: Alejandro Borrego-Ruiz
              Considering the impact of ME/CFS on mental health,
            the exploration of psychobiotics as a therapeutic option   Writing – original draft: Juan J. Borrego
                                                               Writing – review & editing: Alejandro Borrego-Ruiz
            for patients with ME/CFS holds considerable promise.
            Psychobiotics, which target the gut-brain axis, have   Ethics approval and consent to participate
            demonstrated potential in modulating anxiety, depression,
            and stress-related disorders through gut microbiome   Not applicable.
                      60
            adjustments.   Diet  also  offers  possibilities  for  ME/CFS
            symptom management. Specifically, vegetarian diets, rich   Consent for publication
            in antioxidant and fiber, are known to enhance gut health,   Not applicable.
                                                         65
            lower inflammatory markers, and reduce oxidative stress,
            which may be beneficial to mitigate the physiological   Availability of data
            responses commonly reported by patients with ME/CFS.   Not applicable.
            In addition, vegetarian diets may exert a positive influence
            on mental health. 81                               References
              Another interesting aspect related to ME/CFS is to   1.   Nacul L, Authier FJ, Scheibenbogen C,  et al. European
            delineate  the  role  of  microbial  infections,  both  bacterial   network on myalgic encephalomyelitis/chronic fatigue


            Volume 2 Issue 1 (2025)                         22                               doi: 10.36922/mi.4783
   25   26   27   28   29   30   31   32   33   34   35